S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

American College of Surgeons Partners with Arcadia to Modernize Data

The American College of Surgeons is overhauling its clinical data infrastructure through a new partnership with Boston-based health platform Arcadia. The multi-year initiative aims to streamline the collection and analysis of surgical records, shifting the focus from manual administrative tasks to direct improvements in patient outcomes across the nationwide network.

American College of Surgeons Partners with Arcadia to Modernize Data
Photo: Bio & News

For over two decades, the ACS has utilized programs like the National Surgical Quality Improvement Program to establish benchmarks for surgical excellence. By integrating Arcadia’s healthcare performance platform, the college intends to automate data connectivity, allowing hospitals to identify clinical trends without the burden of manual formatting. The goal is to create a cohesive ecosystem where surgical teams can access actionable intelligence in real time.

"This is not a technology initiative. This is a quality improvement strategy," said Patricia L. Turner, MD, MBA, FACS, executive director and CEO of the ACS. Arcadia CEO Michael Meucci noted that the platform is designed to bridge fragmented information, providing clinicians with the foundation necessary to accelerate data-driven innovation. While the methods of gathering and processing information are evolving, the college maintains that its rigorous standards for clinical data remain unchanged.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!